Clinical Trials · NCT05501483

Adipose Tissue Heterogeneity and Its Link to Type 2 Diabetes

Phase
N/A
Recruitment status
Recruiting
Sponsor
Karolinska Institutet
Enrollment
60
Start date
Feb 2023
Locations
1 site, Sweden
Primary endpoint
Changes in fat cell lipolysis after 6 months of treatment
View Semaglutide compound reference